AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2017
Feb 16, 2017
30016_dirs_2017-02-16_d0e4ed46-e32e-4cad-a1a0-6f2f25b5a0d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-02-14
Reporting Person: TWIGGE GIOVANI (CORPORATE VICE PRESIDENT)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-14 | Common Stock | M | 342 | — | Acquired | 18071 | Direct |
| 2017-02-14 | Common Stock | M | 327 | — | Acquired | 18398 | Direct |
| 2017-02-14 | Common Stock | M | 282 | — | Acquired | 18680 | Direct |
| 2017-02-14 | Common Stock | M | 346 | — | Acquired | 19026 | Direct |
| 2017-02-14 | Common Stock | M | 406 | — | Acquired | 19432 | Direct |
| 2017-02-14 | Common Stock | F | 575 | $141.60 | Disposed | 18857 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-14 | Non-Qualified Stock Option (right-to-buy) | $141.60 | A | 10386 | Acquired | 2027-02-13 | Common Stock (10386) | Direct |
| 2017-02-14 | Incentive Stock Option (right-to-buy) | $141.60 | A | 706 | Acquired | 2027-02-13 | Common Stock (706) | Direct |
| 2017-02-14 | Restricted Stock Unit | $ | A | 1059 | Acquired | Common Stock (1059) | Direct | |
| 2017-02-14 | Restricted Stock Unit | $ | M | 342 | Disposed | Common Stock (342) | Direct | |
| 2017-02-14 | Restricted Stock Unit | $ | M | 327 | Disposed | Common Stock (327) | Direct | |
| 2017-02-14 | Restricted Stock Unit | $ | M | 282 | Disposed | Common Stock (282) | Direct | |
| 2017-02-14 | Restricted Stock Unit | $ | M | 346 | Disposed | Common Stock (346) | Direct | |
| 2017-02-14 | Restricted Stock Unit | $ | M | 406 | Disposed | Common Stock (406) | Direct |
Footnotes
F1: Closing price of Issuer's common stock on the NASDAQ market on February 14, 2017.
F2: Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018.
F4: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2013. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").
F5: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014. The number of RSUs have been adjusted to reflect the Stock Split.
F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split.
F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.
F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.
F9: Not applicable.